


Gongwinbiopharm 共信醫藥PTS
Biotechnology Research • Zhongshan District, Taipei City, Taiwan, Province of China • 21-50 Employees
Company overview
| Headquarters | 建國北路一段80號, 3樓, 台北市, 104, TW |
| Phone number | +886225035282 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Atopic Dermatitis, Adenoid Cystic Carcinoma, Central Lung Cancer Tracheal Obstruction, Malignant Pleural Effusion, Primary Liver Cancer, Intratumoral Ablation, Minimally Invasive Tumor Ablation |
| Founded | 2014 |
| Employees | 21-50 |
| Socials |
Key Contacts at Gongwinbiopharm 共信醫藥PTS
Ben Liu
Director
Shunchi Wu
Pre-Clinical Research Director
Gongwinbiopharm 共信醫藥PTS Email Formats
Gongwinbiopharm 共信醫藥PTS uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@gongwinbiopharm.com), used 55.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@gongwinbiopharm.com | 55.6% |
{first name} | john@gongwinbiopharm.com | 22.2% |
{first initial}.{last name} | j.doe@gongwinbiopharm.com | 11.1% |
{first initial}{last name} | jdoe@gongwinbiopharm.com | 11.1% |
About Gongwinbiopharm 共信醫藥PTS
We at Gongwin Biopharm Co., Ltd are researching and developing an innovative ‘Minimally Invasive Targeted Tumor Ablation’ technique for treating focal malignancies. Our proprietary core technology is intra-tumoral injection of PTS (Para Toluene Sulfonamide) by combining the active therapeutic agent and following minimally invasive intervention techniques, which is unique and distinct from traditional anti-tumor therapies that are being opted by medical professionals. Core benefits for patients: Targeted selectivity – Onset within 24hours of injection & almost no damage to adjacent tissue. Broader Efficacy – Application in head & neck, breast, lung, liver & other cancer types. Safety – No severe systemic toxicities.
Gongwinbiopharm 共信醫藥PTS revenue & valuation
| Annual revenue | $12,500,000 |
| Revenue per employee | $544,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $40,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Gongwinbiopharm 共信醫藥PTS has 6 employees across 4 departments.
Departments
Number of employees
Funding Data
Gongwinbiopharm 共信醫藥PTS has never raised funding before.
Gongwinbiopharm 共信醫藥PTS Tech Stack
Discover the technologies and tools that power Gongwinbiopharm 共信醫藥PTS's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Security
JavaScript libraries
Tag managers
Miscellaneous
Security
Miscellaneous
Font scripts
JavaScript frameworks
JavaScript libraries
SSL/TLS certificate authorities
JavaScript libraries
Frequently asked questions
4.8
40,000 users



